Collaboration Details

Print  Close


Title of Collaborative Activity:

Accelerating Medicines Partnership Schizophrenia (AMP SCZ)

Description of Collaborative Activity:

The Foundation for the National Institutes of Health (FNIH), together with National Institute of Mental Health (NIMH) and public and private partners, has launched the Accelerating Medicines Partnership - Schizophrenia (AMP SCZ) as the first neuropsychiatric project within the AMP program. The public-private partnership will tackle the critical need for more effective treatments for people with schizophrenia.

Type of Collaborative Activity:

Research Initiative

Year the Collaborative Activity Originated:

2020

NIH Participating Institutes/Centers/Office of the Director:

HHS Agency Collaborators on this Activity:

FDA